Supernus Pharmaceuticals | SUPN - Market Capitalization


Supernus Pharmaceuticals reported $2.64B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 171.85B 13.8B Jul/2026
ANI Pharmaceuticals USD 1.75B 24M Mar/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Canopy Growth CAD 125.74M 431.39M Jul/2026
Cara Therapeutics USD 366M 338M Sep/2025
Corcept Therapeutics USD 4.32B 654M Mar/2026
Eisai JPY 1.42T 110.62B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Novo Nordisk A/S DKK 1.03T 421.31B Mar/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Xeris Pharmaceuticals USD 1.11B 112M Jul/2026